RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
0.7479
-0.1309 (-14.90%)
At close: May 13, 2025, 4:00 PM
0.7700
+0.0221 (2.95%)
Pre-market: May 14, 2025, 8:08 AM EDT
RAPT Therapeutics Employees
RAPT Therapeutics had 68 employees as of December 31, 2024. The number of employees decreased by 63 or -48.09% compared to the previous year.
Employees
68
Change (1Y)
-63
Growth (1Y)
-48.09%
Revenue / Employee
n/a
Profits / Employee
-$1,713,368
Market Cap
98.94M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RAPT News
- 6 days ago - RAPT Therapeutics Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development - GlobeNewsWire
- 2 months ago - RAPT Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 4 months ago - RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company's Board of Directors - GlobeNewsWire
- 5 months ago - RAPT Therapeutics Announces $150 Million Private Placement - GlobeNewsWire
- 6 months ago - Rapt Therapeutics Stock Plummets, Terminates Asthma Trial Due To Patient's Liver Injury - Benzinga